West Pharmaceutical Servi...

NYSE: WST · Real-Time Price · USD
246.10
-0.10 (-0.04%)
At close: Aug 15, 2025, 3:43 PM

West Pharmaceutical Services Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
492.7M 593.4M 585.9M 661.8M
Depreciation & Amortization
155.4M 137.3M 120.6M 122.3M
Stock-Based Compensation
18.7M 23.3M 23.7M 37.5M
Other Working Capital
16.8M -15.3M 73.2M -600K
Other Non-Cash Items
-16.3M 5.4M 36.1M -900K
Deferred Income Tax
n/a 37.5M -30.8M -42.9M
Change in Working Capital
2.9M -20.4M -15M -193.8M
Operating Cash Flow
653.4M 776.5M 724M 584M
Capital Expenditures
-377M -362M -284.6M -253.4M
Cash Acquisitions
n/a n/a n/a -2.2M
Purchase of Investments
n/a n/a n/a n/a
Sales Maturities Of Investments
n/a n/a n/a n/a
Other Investing Acitivies
-1.7M -6.7M -3.6M 2.5M
Investing Cash Flow
-378.7M -368.7M -288.2M -253.1M
Debt Repayment
-27.6M -2.3M -44.3M -2.2M
Common Stock Repurchased
-566.6M -451.2M -222.2M -151.9M
Dividend Paid
-59.1M -57M -54.1M -51.1M
Other Financial Acitivies
30.7M 50.9M 27M 37.1M
Financial Cash Flow
-622.6M -459.6M -293.6M -168.1M
Net Cash Flow
-369.3M -40.4M 131.7M 147.1M
Free Cash Flow
276.4M 414.5M 439.4M 330.6M